In Jerusalem, medicine crossed a threshold long imagined but never before attempted: a 77-year-old man became the first human being to receive alpha particle radiation delivered directly into a brain tumor, a disease that has resisted nearly every intervention modern oncology has offered. Glioblastoma, which claims most of its patients within a year and a half, has long represented one of medicine's most humbling frontiers — and at Hadassah Medical Center, a technology called Alpha DaRT has now opened a door that was previously sealed. The moment belongs not only to one patient, but to the qui
Hadassah performs world's first alpha radiation treatment for recurrent brain cancer
Glioblastoma affects 150-250 Israelis annually with historically poor outcomes; this treatment offers hope for recurrent cases with limited alternatives.